PLTR vs RTX: Which Is the Better Buy?

Side-by-side comparison of Palantir Technologies Inc. and RTX Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
Palantir Technologies Inc. Β· Technology
$189.67
+2.4% upside to fair value
Med Conviction Grade C High Quality
VS
RTX Corporation Β· Industrials
$193.54
+33.0% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
RTX has more upside to fair value (+33.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric PLTR RTX
Current Price $189.67 $193.54
Fair Value Estimate $194.30 $257.36
Upside to Fair Value +2.4% +33.0%
Market Cap $435.5B $260.9B
Forward P/E β€” β€”
EV / EBITDA 139.9x 18.1x
Price / Sales 70.7x 2.8x
Price / FCF 135.3x 21.7x
Revenue Growth YoY +92.8% +14.5%
Gross Margin 84.8% 20.3%
Operating Margin 42.8% 11.2%
Return on Equity 37.5% 11.8%
Dividend Yield 0% 1.46%
FCF Yield 0.74% 4.6%
Analyst Consensus Hold Buy
Investment Thesis
PLTR β€” Palantir Technologies Inc.
Palantir Technologies Inc. is a software infrastructure company founded in 2003 and headquartered in Denver that builds and deploys Gotham for intelligence and defense workflows, Foundry as a central data operating system for enterprises, Apollo for software delivery across environments, and its Artificial Intelligence Platform (AIP) for unified access to open-source, self-hosted, and commercial …
RTX β€” RTX Corporation
RTX Corporation is a $260.85 billion aerospace and defense conglomerate operating three segments β€” Collins Aerospace, Pratt & Whitney, and Raytheon β€” serving commercial aviation, military, and government customers worldwide with 180,000 employees. The business quality is high: it holds intangible-asset and switching-cost advantages rooted in long-cycle engine programs, proprietary defense electro…
Accumulation Zones
Metric PLTR RTX
Zone Low $145.73 $193.02
Zone High $165.16 $218.76
In Buy Zone? No Yes
← PLTR Research    RTX Research β†’    All Research